founded in 1999, dexcom, inc provides continuous glucose monitoring technology to help patients and their clinicians better manage diabetes. since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions for people with diabetes — while empowering our community to take control of diabetes.
Financial Statements
- Click here to download Dexcom Inc's Income Statement
- Click here to download Dexcom Inc's Balance Sheet
- Click here to download Dexcom Inc's Statement of Cash Flows
Key Info
- Industry: Surgical and Medical Instrument Manufacturing
- Sector: Manufacturing
- CEO Name: Kevin Sayer
Key Statistics
- Stock Price: $100.98
- Dividend Yield: 0%
- Market Capitalization: $40,113,701,142
- Shares Outstanding: 387,871,796
- Number of Employees: 5,328
- Trailing 12-Month EPS: $0.84
- Trailing 12-Month DPS: $0
- Payout Ratio: 0.0%
Important Dates
- Next Earnings Date: 2023-10-26
- Next Ex-Dividend Date:
Price Trends
- Current Stock Price: $100.98
- 52-week high: $139.55
- 52-week low: $78.94
- 200-day moving average: $119.16
- 50-day moving average: $118.51
Performance
- 1-Month Price Return: -21.9%
- 3-Month Price Return: -8.9%
- 6-Month Price Return: -6.5%
- 1-Year Price Return: 25.0%
- 2-Year Price Return: -20.7%
- 5-Year Price Return: 186.5%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast